Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells.
about
Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Proteasome inhibitors prevent ...... HER2+/ER+ breast cancer cells.
@en
Proteasome inhibitors prevent ...... HER2+/ER+ breast cancer cells.
@nl
type
label
Proteasome inhibitors prevent ...... HER2+/ER+ breast cancer cells.
@en
Proteasome inhibitors prevent ...... HER2+/ER+ breast cancer cells.
@nl
prefLabel
Proteasome inhibitors prevent ...... HER2+/ER+ breast cancer cells.
@en
Proteasome inhibitors prevent ...... HER2+/ER+ breast cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Proteasome inhibitors prevent ...... HER2+/ER+ breast cancer cells.
@en
P2093
Arno Schad
Gitta Thiede
Jonathan P Sleeman
Marcus Schmidt
Sonja Thaler
Sven Roβwag
P2860
P304
72281-72301
P356
10.18632/ONCOTARGET.20261
P407
P577
2017-08-14T00:00:00Z